Original Literature | Model OverView |
---|---|
Publication
Title
Nitric oxide and cell viability in inflammatory cells: a role for NO inmacrophage function and fate.
Affiliation
Centro Nacional de Investigaciones Cardiovasculares, Ronda de Poniente 5, TresCantos, 28760 Madrid, Spain. lbosca@cnic.es
Abstract
Macrophages participate actively in the inflammatory response by releasingcytokines, chemokines and factors that recruit additional cells to sites ofinfection or tissue injury or alteration. In addition to this, activatedmacrophages rapidly activate the expression of genes responsible for thehigh-output synthesis of reactive oxygen and nitrogen species (NO, O2-, H2O2 andperoxynitrite, among others) and bioactive lipids derived from arachidonic acid.All of these agents contribute to the regulation of the inflammatory response.Most of these molecules, when synthesized at these high concentrations, exertpro-apoptotic effects in many cell types. Macrophages themselves are a notableand important exception, being resistant to apoptotic death upon activation.This resistance is necessary to enable these cells to perform their functionalrole during the early phases of an inflammatory response. However, aftercumulative damage, or when the synthesis of inflammatory mediators decreases,macrophages undergo the characteristic mitochondrial-dependent cell deathprogram, contributing in this way to the resolution of the inflammatoryreaction. In the case of infectious diseases, this also helps to prevent thedevelopment of parasitic strategies by phagocytosed pathogens.
PMID
15691589
|
Entity
iNOS
--
G010514
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93479
10
infinite
0
TRANSFAC | G010514 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
Fas
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
Procaspase
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
csml-variable:Double
m13
0
infinite
0
--
IAP family
--
e14
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m14
0
infinite
0
--
Procaspase{nitrosylated}
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
Caspase{nitrosylated}
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
proteosome
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
proteosome{nitrosylated}
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
p50:p65
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
p50{nitrosylated}:p65{nitrosylated}
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
15-dPGJ2
--
e21
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
IKK
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
IKK{active}
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
Oxygen superoxide
--
e24
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
Peroxynitrite
--
e25
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
PPAR
--
e26
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m26
0
infinite
0
--
LXRs
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
Fatty acid
--
e28
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
PPAR:Fatty acid
--
e29
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Prostanoids
--
e30
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
PPAR:Prostanoids
--
e31
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m31
0
infinite
0
--
Oxysterols
--
e32
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
LXRs:Oxysterols
--
e33
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m33
0
infinite
0
--
1400W
--
e34
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
1-NIL
--
e35
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
IL-1beta
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
TNF-alpha
--
e37
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m37
0
infinite
0
--
AP-1
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
AP-1{active}
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
NF-KappaB{active}
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
NF-kappaB
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
STAT-1
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
STAT-1{active}
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
IRf-1
--
e44
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m44
0
infinite
0
--
IRf-1{active}
--
e45
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m45
0
infinite
0
--
MMps
--
e46
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m46
0
infinite
0
--
COX-2
--
e47
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m47
0
infinite
0
--
NO
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TGF-beta
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m12*0.1
nodelay
--
0
PMID: 15691589,12605597,9733516 These include the ¡Ædesensitization¡Ç of the initial pro-apoptotic signaling pathway (although the mechanisms of this have been little studied), the inhibition of procaspase processing and caspase activity and the expression of anti-apoptotic genes of the Inhibitor of Apoptosis (IAP) family
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m5*m13*0.1
nodelay
--
0
PMID: 15691589 The active sites of caspase enzymes contain a cysteine residue that is susceptible to S-nitrosylation by NO in the procaspase and active forms of the proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m5*m17*0.1
nodelay
--
0
PMID: 15691589 This occurs through a mechanism that involves nitrosylation of the proteasome and of the p50 and p65 subunits at their DNA binding domains; inhibiting their transcriptional activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m5*m19*0.1
nodelay
--
0
PMID: 15691589 This occurs through a mechanism that involves nitrosylation of the proteasome and of the p50 and p65 subunits at their DNA binding domains; inhibiting their transcriptional activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m21*m22*0.1
nodelay
--
0
PMID: 15691589,9422508 This potent anti-inflammatory molecule efficiently inhibits IKappaB kinase (IKK) activation, as well as the transcriptional activity of several factors such as NF-KappaB, AP-1 and Stat-1alpha
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m5*m21*0.1
nodelay
--
0
PMID: 15691589 Moreover, 15-dPGJ2 synergizes with NO by enhancing the synthesis of reactive oxygen species, in particular oxygen superoxide.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m24*m5*0.1
nodelay
--
0
PMID: 15691589,11086094,10593878,11175752,12893946,12727142 Superoxide rapidly reacts withNO to produce peroxynitrite, one of the most potent oxidants released by cells, and exhibits both pro-apoptotic and necrotic effects
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m28*m26*0.1
nodelay
--
0
PMID: 15691589,10669746,12612088,12524534 These nuclear receptors ? respectively activated by fatty acids/prostanoids and oxysterols ? exert an important down-regulatory control on the transcriptional activity of pro-inflammatory genes and on transcription factors such as NF-KappaB, Stat-1alpha, and AP-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m30*m26*0.1
nodelay
--
0
PMID: 15691589,10669746,12612088,12524534 These nuclear receptors ? respectively activated by fatty acids/prostanoids and oxysterols ? exert an important down-regulatory control on the transcriptional activity of pro-inflammatory genes and on transcription factors such as NF-KappaB, Stat-1alpha, and AP-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m32*m27*0.1
nodelay
--
0
PMID: 15691589,10669746,12612088,12524534 These nuclear receptors ? respectively activated by fatty acids/prostanoids and oxysterols ? exert an important down-regulatory control on the transcriptional activity of pro-inflammatory genes and on transcription factors such as NF-KappaB, Stat-1alpha, and AP-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m37*m38*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p1
p2
cso30:i:CE_Apoptosis_InhibitionOfCellSurvival_
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*0.1
nodelay
--
0
PMID: 15691589,7528106 For example, moderate NO concentrations inhibit basal apoptosis in B lymphocytes, apoptosis induced by the potent cytokine TGF-beta in hepatocytes, and Fas-dependent apoptosis in several cellular models of inflammation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m37*m41*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m37*m42*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m37*m44*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m155666*m44*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m155666*m42*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m155666*m38*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m155666*m41*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m1639*m42*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m1639*m44*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p19
p29
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m1639*m41*0.1
nodelay
--
0
PMID: 15691589 Figure 3
p1
p3
cso30:i:CE_Apoptosis_InhibitionOfCellSurvival_
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m11*0.1
nodelay
--
0
PMID: 15691589,7528106 For example, moderate NO concentrations inhibit basal apoptosis in B lymphocytes, apoptosis induced by the potent cytokine TGF-beta in hepatocytes, and Fas-dependent apoptosis in several cellular models of inflammation
p19
p30
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m1639*m38*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m36*m38*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m36*m41*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m36*m42*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m36*m44*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m43*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m45*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m40*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m39*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m40*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
1.0*0.1
nodelay
--
0
PMID: 15691589,12605597,9733516 These include the ¡Ædesensitization¡Ç of the initial pro-apoptotic signaling pathway (although the mechanisms of this have been little studied), the inhibition of procaspase processing and caspase activity and the expression of anti-apoptotic genes of the Inhibitor of Apoptosis (IAP) family
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m39*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m43*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m45*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m40*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m39*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m43*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m45*0.1
nodelay
--
0
PMID: 15691589 Figure 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c11 : 1
m93479*0.1
nodelay
--
0
PMID: 15691589 Elevated nitric oxide synthesis after the induced expression of NOS-2 by activated macrophages is one of the main cytostatic, cytotoxic, and pro-apoptotic mechanisms participating in the innate response in many mammals PMID: 15691589 A process that can be demonstrated when NO synthesis is suppressed via treatment of cells with a selective NOS-2 inhibitor such as N-(3-aminomethylbenzyl)acetamidine (1400 W) or l-N6-(1-iminoethyl)lysine (l-NIL).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m5*0.1
nodelay
--
0
PMID: 15691589,11129661 The pro-apoptotic activity of NO has been well documented and involves the release of cytochrome c from the mitochondria, increased expression of the tumor suppressor p53 and accumulation and targeting of pro-apoptotic members of the Bcl-2 family, in particular Bax, which is translocated to the mitochondria
p7
p7
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m155666*0.1
nodelay
--
0
PMID: 15691589 In contrast, molecules that release NO in a sustained way, or induction of NOS-2 expression by treatment with lipopolysaccharide (LPS) and IFN- gamma, do not provoke this response
p7
p8
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c16 : 1
m1639*0.1
nodelay
--
0
PMID: 15691589 In contrast, molecules that release NO in a sustained way, or induction of NOS-2 expression by treatment with lipopolysaccharide (LPS) and IFN- gamma, do not provoke this response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c20 : 1
stoichiometry:c19 : 1
m12*m5*0.1
nodelay
--
0
PMID: 15691589 The active sites of caspase enzymes contain a cysteine residue that is susceptible to S-nitrosylation by NO in the procaspase and active forms of the proteins.
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--